Woodford buys $50M Prothena stake, Shire lacks ‘British gem’ status, French biotechs raise €100M

Nick Paul Taylor

Welcome to the latest edition of our weekly EuroBiotech Report. We lead this week on news that Neil 's much-discussed fund is starting to take shape, with a $ 50 million (€36.8 million) investment in Elan-spinoff among its first batch of positions. And more.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS